The Marquette University and Medical College of Wisconsin Department of Biomedical Engineering is dedicated to the development and application of novel technologies in biomedical research.
It has five major areas of focus: proteomics, genomics, computational biology, molecular imaging, and technology development, each with an emphasis on the application and transfer of technology. One of the major goals is to help create productive interfaces and synergy between the various academic departments at MCW, other universities both within Wisconsin and nationally, and with the biotechnology and pharmaceutical industries.
The director is Andrew S. Greene, PhD, Professor of Physiology.
The MCW Cardiovascular Center, directed by Ivor Benjamin, MD, FAHA, FACC, translates biological science into clinical applications for care and treatment of patients. CVC physicians serve patients with heart and vascular diseases at Froedtert Hospital, Children's Hospital of Wisconsin, the Clement J. Zablocki Veterans Administration Medical Center and other regional facilities.
CVC researchers, working in one of the largest laboratory complexes in the U.S., have made significant accomplishments toward understanding and preventing diseases such as stroke, atherosclerosis, hypertension, and diabetes. The National Institutes of Health named the MCW CVC a Specialized Center for Research on Hypertension, one of only five in the U.S. Established in 1992, the Cardiovascular Center has more than 150 physicians and scientists from 23 departments at the Medical College of Wisconsin involved in multi-disciplinary research.
The Center of Systems Molecular Medicine at the Medical College of Wisconsin is directed by Mingyu Liang, MB, PhD, Eminent Scholar, Professor of Physiology. The mission of the CoSMM is to develop and apply systems molecular approaches to improve the understanding and treatment of human disease. The primary function of the CoSMM is to serve as an intellectual incubator for research and project development. The current areas of focus at the CoSMM are microRNA, epigenomics, and related translational research.
The Genomic Sciences and Precision Medicine Center (GSPMC) at MCW has its roots in the launch of the Human Genome Project and the 1999 founding of the MCW Human and Molecular Genetics Center. The Human and Molecular Genetics Center had the goal of developing and promoting genomic technologies and approaches and applying them to the study of genetic disorders. The plan called for developing the research expertise to capitalize on the remarkable progress of the Human Genome Project. Having the entire sequence of the human genome and several other model organisms and pathogens means that, in principle, for the first time scientists have a full compendium of genes related to health and disease. Over the next several decades, our scientists will focus on defining gene function (functional genomics) and how genes interact with each other and the environment to produce disease. The GSPMC is charged with developing the critical infrastructure needed to position the Medical College of Wisconsin as a leader in functional genomics. The investigators currently part of the GSPMC work in the areas of bioinformatics, genomics, high-throughput sequencing, and the development and use of single nucleotide polymorphisms (SNPs), expression analysis (microarray), and translational biology (transgenic and knock-out technologies).